Chemed CHE Segment Vitas — Net Income Loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's segment vitas — net income loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Chemed's segment vitas — net income loss?
- Chemed (CHE) reported segment vitas — net income loss of $52.21M in Q1 2026.
- How has Chemed's segment vitas — net income loss changed year-over-year?
- Chemed's segment vitas — net income loss increased by 4.4% year-over-year, from $50.03M to $52.21M.
- What is the long-term trend for Chemed's segment vitas — net income loss?
- Over 4 years (2021 to 2025), Chemed's segment vitas — net income loss has grown at a 5.9% compound annual growth rate (CAGR), from $162.43M to $204.01M.
- What does segment vitas — net income loss mean?
- This metric represents the final bottom-line profit or loss of the segment after accounting for all revenues, operating expenses, interest, taxes, and non-operating items. It provides the most comprehensive view of the segment's financial contribution to the overall corporation.